Your browser doesn't support javascript.
loading
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia.
Gregorova, Michaela; Morse, Daniel; Brignoli, Tarcisio; Steventon, Joseph; Hamilton, Fergus; Albur, Mahableshwar; Arnold, David; Thomas, Matthew; Halliday, Alice; Baum, Holly; Rice, Christopher; Avison, Matthew B; Davidson, Andrew D; Santopaolo, Marianna; Oliver, Elizabeth; Goenka, Anu; Finn, Adam; Wooldridge, Linda; Amulic, Borko; Boyton, Rosemary J; Altmann, Daniel M; Butler, David K; McMurray, Claire; Stockton, Joanna; Nicholls, Sam; Cooper, Charles; Loman, Nicholas; Cox, Michael J; Rivino, Laura; Massey, Ruth C.
Afiliación
  • Gregorova M; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Morse D; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Brignoli T; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Steventon J; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Hamilton F; North Bristol NHS Trust, Bristol, United Kingdom.
  • Albur M; North Bristol NHS Trust, Bristol, United Kingdom.
  • Arnold D; North Bristol NHS Trust, Bristol, United Kingdom.
  • Thomas M; North Bristol NHS Trust, Bristol, United Kingdom.
  • Halliday A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Baum H; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Rice C; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Avison MB; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Davidson AD; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Santopaolo M; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Oliver E; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Goenka A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Finn A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Wooldridge L; Bristol Veterinary School in the Faculty of Health Sciences, Bristol, United Kingdom.
  • Amulic B; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Boyton RJ; Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • Altmann DM; Lung Division, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.
  • Butler DK; Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • McMurray C; Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • Stockton J; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
  • Nicholls S; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
  • Cooper C; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
  • Loman N; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
  • Cox MJ; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
  • Rivino L; Lung Division, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.
  • Massey RC; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Elife ; 92020 12 17.
Article en En | MEDLINE | ID: mdl-33331820
ABSTRACT
Here, we describe the case of a COVID-19 patient who developed recurring ventilator-associated pneumonia caused by Pseudomonas aeruginosa that acquired increasing levels of antimicrobial resistance (AMR) in response to treatment. Metagenomic analysis revealed the AMR genotype, while immunological analysis revealed massive and escalating levels of T-cell activation. These were both SARS-CoV-2 and P. aeruginosa specific, and bystander activated, which may have contributed to this patient's persistent symptoms and radiological changes.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Pseudomonas / Activación de Linfocitos / Linfocitos T / Neumonía Asociada al Ventilador / SARS-CoV-2 / COVID-19 / Antibacterianos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Elife Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Pseudomonas / Activación de Linfocitos / Linfocitos T / Neumonía Asociada al Ventilador / SARS-CoV-2 / COVID-19 / Antibacterianos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Elife Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido